Fig. 7From: Effect of Pimobendan on NT-proBNP and c troponin I before and after a submaximal exercise test in dogs with preclinical mitral valve disease without cardiomegaly – a randomised, double-blinded trialChanges after exercise in NT-proBNP. There is a significant difference (*) between the Pimobendan-group and the placebo-group at day 180 (p = 0.03)Back to article page